A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Alignment Healthcare, Inc.
ALHC
$4.0B
Mkt Cap
$19.43
-2.85%
Alignment Healthcare, Inc. (ALHC) has a 5-year average return on invested capital (ROIC) of -34.6%. This is below average and may indicate limited pricing power.
Alignment Healthcare, Inc. (ALHC) has a market capitalization of $4.0B. It is classified as a mid-cap stock.
Alignment Healthcare, Inc. (ALHC) does not currently pay a regular dividend.
Alignment Healthcare, Inc. (ALHC) operates in the Hospital & Medical Service Plans industry, within the Financials sector.
Alignment Healthcare, Inc. (ALHC) reported annual revenue of $3.9 billion in its most recent fiscal year, based on SEC EDGAR filings.
Alignment Healthcare, Inc. (ALHC) has a net profit margin of -0.0%. The company is currently unprofitable.
Alignment Healthcare, Inc. (ALHC) generated $113 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Our Mission: Improve Healthcare, One Senior at a Time Alignment Healthcare was founded in 2013 with one mission: improve healthcare, one senior at a time. We pursue this mission by focusing on our core values: •always put the senior first; •support the doctor; •use data and technology to revolutionize care; and •act with a serving heart. We created Alignment after our own families faced frustrating experiences within the fragmented healthcare system. Without an advocate to create an integrated, high quality healthcare experience for them, our loved ones were left to navigate a care delivery and insurance landscape fraught with confusion and complexity. Seniors across the country are systemically and disproportionately impacted by the lack of care coordination, transparency and clear information. Furthermore, they are disadvantaged by misaligned incentives that dominate today’s healthcare system. As one of our most vulnerable populations, seniors across America need and deserve better.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 4.3B | 3.9B | 2.7B | 1.8B | 1.4B | 1.2B |
| Net Income | 20M | -724K | -128M | -148M | -150M | -195M |
| EPS | $0.10 | $-0.00 | $-0.67 | $-0.79 | $-0.83 | $-1.14 |
| Free Cash Flow | 226M | 113M | -6.6M | -95M | -69M | -79M |
| ROIC | 2.8% | -0.2% | -34.6% | -41.2% | -35.0% | -61.9% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 1.56 | 1.80 | 3.22 | 1.03 | 0.68 | 0.49 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 36M | 15M | -102M | -128M | -129M | -178M |
| Operating Margin | 0.8% | 0.4% | -3.8% | -7.0% | -9.0% | -15.2% |
| ROE | 9.6% | -0.5% | -99.7% | -74.9% | -55.0% | -116.0% |
| Shares Outstanding | 207M | 204M | 191M | 187M | 180M | 171M |
| Metric | ||||||||
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 757M | 959M | 1.2B | 1.4B | 1.8B | 2.7B | 3.9B | 4.3B |
| Gross Margin | 0.0% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 110M | 156M | 291M | 296M | 307M | 371M | 443M | 461M |
| EBIT | -29M | -5.3M | -178M | -129M | -128M | -102M | 15M | 36M |
| Op. Margin | -3.9% | -0.5% | -15.2% | -9.0% | -7.0% | -3.8% | 0.4% | 0.8% |
| Net Income | -45M | -23M | -195M | -150M | -148M | -128M | -724K | 20M |
| Net Margin | -5.9% | -2.4% | -16.7% | -10.4% | -8.1% | -4.7% | -0.0% | 0.5% |
| Non-Recurring | -418K | -1.0M | 0 | -101K | 0 | 9K | 72K | 72K |
| Returns on Capital | ||||||||
| ROIC | N/A | -30.4% | -61.9% | -35.0% | -41.2% | -34.6% | -0.2% | 2.8% |
| ROE | 79.6% | 95.3% | -116.0% | -55.0% | -74.9% | -99.7% | -0.5% | 9.6% |
| ROA | N/A | -13.5% | -40.3% | -23.6% | -24.2% | -18.6% | -0.1% | 1.6% |
| Cash Flow | ||||||||
| Op. Cash Flow | 9.2M | 7.6M | -79M | -45M | -59M | 35M | 140M | 252M |
| Free Cash Flow | 9.2M | 7.6M | -79M | -69M | -95M | -6.6M | 113M | 226M |
| Owner Earnings | -5.7M | -8.0M | -95M | -144M | -147M | -63M | 47M | 162M |
| CapEx | 0 | 0 | 0 | 24M | 36M | 41M | 27M | 26M |
| Maint. CapEx | 15M | 15M | 16M | 17M | 21M | 27M | 30M | 31M |
| Growth CapEx | N/A | N/A | N/A | 6.5M | 15M | 15M | 0 | 0 |
| D&A | 15M | 15M | 16M | 17M | 21M | 27M | 30M | 31M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | 119.1% | 19.1% | 10.3% |
| Capital Allocation | ||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 2.0M | 1.5M | 1.5M | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | N/A | 0.1% | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 0 | 446K | 621K | 82M | 67M | 71M | 62M | 59M |
| Debt Repayment | 0 | 0 | 0 | 143M | 0 | 215M | 0 | 0 |
| Balance Sheet | ||||||||
| Net Debt | -31M | -63M | -316M | -249M | -157M | -149M | -281M | -403M |
| Cash & Equiv. | 86M | 207M | 467M | 410M | 203M | 433M | 576M | 726M |
| Long-Term Debt | 55M | 144M | 151M | 161M | 162M | 321M | 323M | 324M |
| Debt/Equity | -0.70 | 4.71 | 0.49 | 0.68 | 1.03 | 3.22 | 1.80 | 1.56 |
| Interest Coverage | -2.0 | -0.3 | -10.2 | -7.0 | -6.0 | -4.3 | 0.9 | 16.9 |
| Equity | -79M | 31M | 306M | 238M | 157M | 100M | 179M | 207M |
| Total Assets | N/A | 339M | 631M | 634M | 592M | 782M | 1.1B | 1.3B |
| Total Liabilities | N/A | 308M | 325M | 395M | 434M | 681M | 887M | 1.1B |
| Intangibles | N/A | 35M | 35M | 5.5M | 5.3M | 4.5M | 4.5M | 4.5M |
| Retained Earnings | N/A | -380M | -583M | -732M | -880M | -1.0B | -1.0B | -998M |
| Working Capital | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Assets | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Liabilities | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Per Share Data | ||||||||
| EPS | -0.33 | -0.15 | -1.14 | -0.83 | -0.79 | -0.67 | -0.00 | 0.10 |
| Owner EPS | -0.04 | -0.05 | -0.56 | -0.80 | -0.79 | -0.33 | 0.23 | 0.79 |
| Book Value | -0.58 | 0.20 | 1.79 | 1.32 | 0.84 | 0.52 | 0.88 | 1.00 |
| Cash Flow/Share | 0.07 | 0.05 | -0.46 | -0.25 | -0.32 | 0.18 | 0.69 | 0.24 |
| Dividends/Share | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 135.6M | 152.8M | 171.3M | 180.2M | 187.4M | 191.1M | 204.2M | 206.7M |
| Valuation | ||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 196.0 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | 33.9 | 17.8 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | 241.0 | 101.4 |
| Price/Book | N/A | N/A | 7.9 | 8.6 | 10.4 | 20.7 | 21.4 | 19.4 |
| Price/Sales | N/A | N/A | 3.0 | 1.5 | 0.8 | 0.6 | 0.8 | 0.9 |
| FCF Yield | N/A | N/A | -3.3% | -3.4% | -5.8% | -0.3% | 2.9% | 5.6% |
| Market Cap | 0 | N/A | 2.4B | 2.0B | 1.6B | 2.1B | 3.8B | 4.0B |
| Avg. Price | 0.00 | N/A | 20.45 | 11.64 | 7.38 | 8.53 | 15.89 | 19.43 |
| Year-End Price | 0.00 | N/A | 14.04 | 11.33 | 8.74 | 10.82 | 18.78 | 19.43 |
Alignment Healthcare, Inc. passes 3 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 35.1x vs a median of 33.9x. At current prices, the estimated annualized return to fair value is +20.5%.
Alignment Healthcare, Inc. (ALHC) has a debt-to-equity ratio of 1.80. This indicates higher leverage, which may increase financial risk.
Alignment Healthcare, Inc. (ALHC) reported earnings per share (EPS) of $-0.00 in its most recent fiscal year.
Alignment Healthcare, Inc. (ALHC) has a return on equity (ROE) of -0.5%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 7 years of financial data for Alignment Healthcare, Inc. (ALHC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Alignment Healthcare, Inc. (ALHC) has a book value per share of $0.88, based on its most recent annual SEC filing.